Carbidopa/Melevodopa
N/A
Report date: 2022/01/14 13:23:58
Base Information
Drug NameCarbidopa/Melevodopa
Drug Alias Name +[8]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2003/01/01
Country/Territory
CombinationsYes Levodopa Methyl Ester HydrochlorideCarbidopa
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesChiesi Farmaceutici SPA
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesCita Neuropharmaceuticals IncVernalis (R&D) Ltd
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A